Psychedelic Drug Discovery Platform + Strategy

Drug Discovery Platform

Enlightenment Mental Health is working on developing partnerships with Biotech and Technology companies to assist in the early pre-clinical stage development of novel therapeutics for treatment of Mental Illnesses.

We shall pursue therapeutic discovery of both, synthesized and naturally based Psychedelic compounds.

Our Discovery strategy allows us to collaborate with Biotechnology partners to help us scale our drug discovery in early stages.

The Model leverages the Laboratory infrastructure of our partners without the need for capital infrastructure investment.

Our goal to create a Portfolio of Intellectual Property of Early-Stage Novel Psychedelic Molecular Discoveries that can be potentially commercialized by licensing.

Drug Discovery Strategy
Polaris QB

We have entered into a preliminary agreement with Polaris qb, a drug discovery company focused on utilizing Quantum Computing, Artificial Intelligence (Ai) and Machine Learning (ML) to speed drug discovery & formulation development process. Our goal is to develop a Psilocybin based therapeutic compound.

PsyRX Biotech Company

We have entered into a preliminary agreement with PsyRX, an Israeli Government Licensed Biotech Company with Labs at Hebrew University, Tel Aviv. Developing Psychedelic Organic Compounds for Psilocybin & Ibogaine.

Quantum Technology

Quantum Technology + Artificial Intelligence (Ai) + Machine Learning (Ml)

Receptor(s) Targeting. Psilocybin Impacts the Serotonin Receptors. Diagnosis: Serotonin Receptors(s)

  • POST- TRAUMATIC STRESS DISORDER (PTSD): 5HT2A
  • DEPRESSION: 5HT2AR, 5HT2A
  • DEPRESSION CO-MORBIDITY: 5HT2AR, 5HT2A
  • ANXIETY: 5HT2A, 5HT1A, 5HT2C
  • ANXIETY CO-MORBIDITY: 5HT2A, 5HT1A, 5HT2
  • END-OF-LIFE ANXIETY: 5HT2A, 5HT1A, 5HT2C
  • OCD: 5HT1A, 5HT2A, 5HT2C
  • ADDICTIONS: 5HT2AR

  • SUBSTANCE USE DISORDER: 5HT2A, 5HT2C,T2C
  • ALCOHOL USE DISORDER: 5HT2A
  • TOBACCO USE DISORDER: 5HT2A
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram